Thomas J. Schaefer - 19 Aug 2024 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RKDA	Stock Option (Right to Buy)	Award	$0	+20,000	+365%	$0.000000	25,475	19 Aug 2024	Common Stock	20,000	$2.71	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.